When compared to conventional serological markers of active LN, thrombomodulin level was more sensitive (89.66%) than anti-dsDNA antibody and C3 levels in distinguishing active LN from remission and showed less specificity (68.97%) to conventional biomarkers (53). This evidence concerns the gene C3 and lobular neoplasia.